ARDT stock news · Ardent Health
Get alerts for ARDT
Follow Ardent Health (ARDT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ARDTFree on the App Store and Google Play, or on the web.
Stephens & Co. and RBC Capital Markets increased their price targets for Ardent Health after its better-than-expected third-quarter results.
Good for ARDTAnalysts raised Ardent's targets from $13 to $21 per share and from $13 to $18 per share. Lower labor costs support a positive read.
Ardent Health, Inc. says its CEO is leaving, and he won't get severance pay.
NeutralArdent Health reclassified its former CEO's departure as for cause and stopped about $4.5 million in severance. The finding raises oversight concerns, but past financial reports remain unchanged, leaving no clear overall direction.